Literature DB >> 11926811

Novel antisense and peptide nucleic acid strategies for controlling gene expression.

Dwaine A Braasch1, David R Corey.   

Abstract

Antisense oligonucleotides have the potential to make revolutionary contributions to basic science and medicine. Oligonucleotides can bind mRNA and inhibit translation. Because they can be rapidly synthesized to be complementary to any sequence, they offer ideal tools for exploiting the massive amount of genome information now available. However, until recently, this potential was largely theoretical, and antisense experiments often produced inconclusive or misleading outcomes. This review will discuss the chemical and biological properties of some of the different types of oligomers now available and describe the challenges confronting in vitro and in vivo use of oligonucleotides. Oligomers with improved chemical properties, combined with advances in cell biology and success in clinical trials, are affording powerful new options for basic research, biotechnology, and medicine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926811     DOI: 10.1021/bi0122112

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  43 in total

1.  Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.

Authors:  Dwaine A Braasch; Yinghui Liu; David R Corey
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Pseudocomplementary PNAs as selective modifiers of protein activity on duplex DNA: the case of type IIs restriction enzymes.

Authors:  Ekaterina Protozanova; Vadim V Demidov; Peter E Nielsen; Maxim D Frank-Kamenetskii
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

Review 3.  RNA interference: from an ancient mechanism to a state of the art therapeutic application?

Authors:  Christoph Arenz; Ute Schepers
Journal:  Naturwissenschaften       Date:  2003-07-23

4.  Tailoring the activity of restriction endonuclease PleI by PNA-induced DNA looping.

Authors:  Ekaterina Protozanova; Vadim V Demidov; Viatcheslav Soldatenkov; Sergey Chasovskikh; Maxim D Frank-Kamenetskii
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

5.  NMR solution structure of a parallel LNA quadruplex.

Authors:  Antonio Randazzo; Veronica Esposito; Oliver Ohlenschläger; Ramadurai Ramachandran; Luciano Mayola
Journal:  Nucleic Acids Res       Date:  2004-06-04       Impact factor: 16.971

6.  Small interfering RNAs containing full 2'-O-methylribonucleotide-modified sense strands display Argonaute2/eIF2C2-dependent activity.

Authors:  Bryan A Kraynack; Brenda F Baker
Journal:  RNA       Date:  2005-11-21       Impact factor: 4.942

7.  DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells.

Authors:  A P Simões-Wüst; B Sigrist; L Belyanskaya; S Hopkins Donaldson; R A Stahel; U Zangemeister-Wittke
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

Review 8.  Chemical modification: the key to clinical application of RNA interference?

Authors:  David R Corey
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers.

Authors:  Latha M Santhakumaran; Thresia Thomas; T J Thomas
Journal:  Nucleic Acids Res       Date:  2004-04-15       Impact factor: 16.971

Review 10.  Telomerase inhibition in cancer therapeutics: molecular-based approaches.

Authors:  A P Cunningham; W K Love; R W Zhang; L G Andrews; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.